Development of acquired haemophilia A in a patient treated with alemtuzumab for multiple sclerosis

This case illustrates a 36-year-old man who presented with a factor VIII (FVIII) inhibitor (acquired haemophilia A) with cutaneous bleeding and a significant thigh haematoma. No traditional risk factors for the development of a FVIII inhibitor were identified. However, previous treatment with alemtu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ Case Rep
Hauptverfasser: Madeley, Jarrett, Hodges, Georgina, Birchley, Andrew
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Publishing Group 2018
Schlagworte:
Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6254386/
https://ncbi.nlm.nih.gov/pubmed/30337289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-226588
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge